Want full text access to this journal?
Use Read by QxMD to access full text via your institution or open access sources.
Read also provides personalized recommendations to keep you up to date in your field.
Existing User
Sign InNew to Read
Sign UpJournal of the American College of Cardiology
• journal#1
EDITORIAL
Christopher P Cannon
No abstract text is available yet for this article.
March 21, 2020: Journal of the American College of Cardiology
#2
George P Rodgers, Jane A Linderbaum, Dorothy D Pearson, Susan M Fernandes, Susan D Housholder-Hughes, Lisa A Mendes, Nancy C Berg, Jennifer Day, David Drajpuch, Blair Erb, Marci Farquhar-Snow, Heather Johnson, Patricia Keegan, Christine Kindler, Rhonda Larsen, Viet T Le, Michelle J Nickolaus, Celeste M Phillips, Laura Ross, Sherrie R Webb, Erica S Zado
No abstract text is available yet for this article.
March 18, 2020: Journal of the American College of Cardiology
#3
REVIEW
Elissa Driggin, Mahesh V Madhavan, Behnood Bikdeli, Taylor Chuich, Justin Laracy, Giuseppe Bondi-Zoccai, Tyler S Brown, Caroline Der Nigoghossian, David A Zidar, Jennifer Haythe, Daniel Brodie, Joshua A Beckman, Ajay J Kirtane, Gregg W Stone, Harlan M Krumholz, Sahil A Parikh
The coronavirus disease-2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 that has significant implications for the cardiovascular care of patients. First, those with COVID-19 and preexisting cardiovascular disease (CVD) have an increased risk of severe disease and death. Second, infection has been associated with multiple direct and indirect cardiovascular complications including acute myocardial injury, myocarditis, arrhythmias and venous thromboembolism. Third, therapies under investigation for COVID-19 may have cardiovascular side effects...
March 18, 2020: Journal of the American College of Cardiology
#4
Frederick G P Welt, Pinak B Shah, Herbert D Aronow, Anna E Bortnick, Timothy D Henry, Matthew W Sherwood, Michael N Young, Laura J Davidson, Sabeeda Kadavath, Ehtisham Mahmud, Ajay J Kirtane
No abstract text is available yet for this article.
March 16, 2020: Journal of the American College of Cardiology
#5
LETTER
Lakshmi Nambiar, Martin M LeWinter, Peter C VanBuren, Harold L Dauerman
No abstract text is available yet for this article.
March 13, 2020: Journal of the American College of Cardiology
#6
LETTER
Tom Kai Ming Wang Mbchb, Jorge Betancor, Natalie Ho, L Leonardo Rodriguez, Christine L Jellis, Brian P Griffin, Bo Xu
No abstract text is available yet for this article.
March 13, 2020: Journal of the American College of Cardiology
#7
EDITORIAL
Walter J Paulus
No abstract text is available yet for this article.
March 11, 2020: Journal of the American College of Cardiology
#8
Ravi B Patel, Laura A Colangelo, Alexander P Reiner, Myron D Gross, David R Jacobs, Lenore J Launer, Joao A C Lima, Donald M Lloyd-Jones, Sanjiv J Shah
BACKGROUND: E-selectin and intercellular adhesion molecule-1 (ICAM-1) are biomarkers of endothelial activation, which has been implicated in the pathogenesis of heart failure (HF) with preserved ejection fraction (HFpEF). However, the temporal associations between E-selectin and ICAM-1 with subclinical cardiac dysfunction are unclear. OBJECTIVES: To assess the longitudinal associations of E-selectin and ICAM-1 with subclinical alterations in cardiac function. METHODS: In the Coronary Artery Disease Risk Development in Young Adults study, a cohort of black and white young adults, we evaluated the associations of E-selectin and ICAM-1, obtained at year 7 (Y7) and Y15 examinations, with cardiac function assessed at Y30 after adjustment for key covariates...
March 11, 2020: Journal of the American College of Cardiology
#9
Michael Szarek, Pierre Amarenco, Alfred Callahan, David DeMicco, Rana Fayyad, Larry B Goldstein, Rachel Laskey, Henrik Sillesen, K Michael Welch
BACKGROUND: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial compared atorvastatin with placebo in 4,731 participants with recent stroke or transient ischemic attack and no known coronary heart disease. Atorvastatin reduced the first occurrence of stroke and the first occurrence of a composite of vascular events. OBJECTIVES: This post hoc analysis assessed the occurrence of all (first and subsequent) vascular events and the effect of atorvastatin to reduce these events by vascular territory (cerebrovascular, coronary, or peripheral) in SPARCL...
March 11, 2020: Journal of the American College of Cardiology
#10
Senthil Selvaraj, Brian L Claggett, Michael Böhm, Stefan D Anker, Muthiah Vaduganathan, Faiez Zannad, Burkert Pieske, Carolyn S P Lam, Inder S Anand, Victor C Shi, Martin P Lefkowitz, John J V McMurray, Scott D Solomon
BACKGROUND: Guidelines recommend targeting systolic blood pressure (SBP) <130 mm Hg in heart failure with preserved ejection fraction (HFpEF) with limited data. OBJECTIVES: This study sought to determine the optimal achieved SBP and whether the treatment effects of sacubitril/valsartan on outcomes are related to BP lowering, particularly among women who derive greater benefit from sacubitril/valsartan. METHODS: Using 4,795 trial participants, this study related baseline and time-updated mean achieved SBP quartiles (<120, 120 to 129, 130 to 139, ≥140 mm Hg) to the primary outcome (cardiovascular death and total heart failure hospitalization), its components, myocardial infarction or stroke, and a renal composite outcome...
March 11, 2020: Journal of the American College of Cardiology
#11
EDITORIAL
Hector O Ventura, Carl J Lavie, Mandeep R Mehra
No abstract text is available yet for this article.
March 10, 2020: Journal of the American College of Cardiology
#12
Suzanne V Arnold, Gregg W Stone, Michael J Mack, Adnan K Chhatriwalla, Bethany A Austin, Zixuan Zhang, Ori Ben-Yehuda, Saibal Kar, D Scott Lim, JoAnn Lindenfeld, William T Abraham, David J Cohen
BACKGROUND: In the COAPT trial, transcatheter mitral valve repair (TMVr) with the MitraClip rapidly improved health status and reduced the long-term risks of death and heart failure (HF) hospitalization in patients with HF and severe secondary mitral regurgitation (SMR) who remained symptomatic despite maximally-tolerated guideline directed medical therapy (GDMT). OBJECTIVE: To examine if early health status changes were associated with long-term clinical outcomes in the COAPT population...
March 4, 2020: Journal of the American College of Cardiology
#13
Marta Guasch-Ferré, Gang Liu, Yanping Li, Laura Sampson, JoAnn E Manson, Jordi Salas-Salvadó, Miguel A Martínez-González, Meir J Stampfer, Walter C Willett, Qi Sun, Frank B Hu
BACKGROUND: Olive oil intake has been associated with lower risk of cardiovascular disease (CVD) in Mediterranean populations, but little is known about these associations in the U.S population. OBJECTIVES: To examine whether olive oil intake is associated with total CVD, coronary heart disease (CHD) and stroke risk. METHODS: We included 61,181 women from the Nurses' Health Study (1990-2014) and 31,797 men from the Health Professionals Follow-up Study (1990-2014) who were free of cancer, heart disease, and stroke at baseline...
February 27, 2020: Journal of the American College of Cardiology
#14
EDITORIAL
Valentin Fuster
No abstract text is available yet for this article.
February 20, 2020: Journal of the American College of Cardiology
#15
Clyde W Yancy, Mark H Drazner, Samuel Tristram Coffin, William Cornwell, Shashank Desai, John P Erwin, Mahazarin Ginwalla, Karol S Harshaw-Ellis, Tamara Horwich, Michelle Kittleson, Anuradha Lala, Sabra C Lewsey, Joseph E Marine, Cindy M Martin, Karen Meehan, David A Morrow, Kelly Schlendorf, Jason W Smith, Gerin R Stevens
No abstract text is available yet for this article.
February 14, 2020: Journal of the American College of Cardiology
#16
Robert O Bonow, Patrick T O'Gara, David H Adams, Vinay Badhwar, Joseph E Bavaria, Sammy Elmariah, Judy W Hung, JoAnn Lindenfeld, Alanna A Morris, Ruby Satpathy, Brian Whisenant, Y Joseph Woo
Mitral regurgitation (MR) is a complex valve lesion that can pose significant management challenges. This Expert Consensus Decision Pathway emphasizes that recognition of MR should prompt an assessment of its etiology, mechanism, and severity, as well as consideration of the indications for treatment. The document is a focused update of the 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation, with some sections updated and others added in light of the publication of new trial data related to secondary MR, among other developments...
February 10, 2020: Journal of the American College of Cardiology
#17
EDITORIAL
Richard J Kovacs, Jason H Gilbert, William J Oetgen
No abstract text is available yet for this article.
January 7, 2020: Journal of the American College of Cardiology
#18
LETTER
Joanna Chikwe, Natalia Egorova, David H Adams
No abstract text is available yet for this article.
March 24, 2020: Journal of the American College of Cardiology
#19
LETTER
Guanghua Tang, Xianshi Zhou
No abstract text is available yet for this article.
March 24, 2020: Journal of the American College of Cardiology
#20
LETTER
Yutao Guo, Tong Liu, Yundai Chen, Gregory Y H Lip
No abstract text is available yet for this article.
March 24, 2020: Journal of the American College of Cardiology
Fetching more papers... 
